Barclays’s Lisata Therapeutics LSTA Stock Holding History

Barclays’s Portfolio LSTA Stock Details LSTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$238	Buy	+70	New	+$249	﹤0.01%	5089
2025 Q4	–	Sell	-4	Closed	-$10	–	5500
2025 Q3	$10	Hold	4	–	–	﹤0.01%	5397
2025 Q2	$12	Hold	4	–	–	﹤0.01%	5152
2025 Q1	$9	Hold	4	–	–	﹤0.01%	5181
2024 Q4	$12	Sell	4 -3	-43%	-$9	﹤0.01%	5224
2024 Q3	$21	Buy	7 +3	+75%	+$9	﹤0.01%	5231
2024 Q2	$14	Hold	4	–	–	﹤0.01%	4785
2024 Q1	$12	Hold	4	–	–	﹤0.01%	5025
2023 Q4	$11	Hold	4	–	–	﹤0.01%	5195
2023 Q3	$9	Sell	4 -23	-85%	-$64	﹤0.01%	4569
2023 Q2	$100	Buy	27 +21	+350%	+$76	﹤0.01%	4443
2023 Q1	$19	Buy	6 +2	+50%	+$7	﹤0.01%	5028
2022 Q4	$10	Hold	4	–	–	﹤0.01%	5239
2022 Q3	$0	Hold	4	–	–	﹤0.01%	4995
2022 Q2	$0	Hold	4	–	–	﹤0.01%	5163
2022 Q1	$0	Hold	4	–	–	﹤0.01%	5340
2021 Q4	$0	Sell	4 -1,403	-100%	-$21.7K	﹤0.01%	4499
2021 Q3	$26K	Buy	1,407 +992	+239%	+$19.4K	﹤0.01%	4318
2021 Q2	$10K	Buy	415 +411	+10,275%	+$9.74K	﹤0.01%	4638
2021 Q1	$0	Hold	4	–	–	﹤0.01%	4986
2020 Q4	$0	Hold	4	–	–	﹤0.01%	5066
2020 Q3	$0	Hold	4	–	–	﹤0.01%	5416
2020 Q2	$0	Hold	4	–	–	﹤0.01%	5969
2020 Q1	$0	Hold	4	–	–	﹤0.01%	6334
2019 Q4	$0	Hold	4	–	–	﹤0.01%	6617
2019 Q3	$0	Hold	4	–	–	﹤0.01%	6952
2019 Q2	$0	Hold	4	–	–	﹤0.01%	7104
2019 Q1	$0	Hold	4	–	–	﹤0.01%	7193
2018 Q4	$0	Hold	4	–	–	﹤0.01%	7151
2018 Q3	$0	Sell	4 -40	-91%	-$3.28K	﹤0.01%	7276
2018 Q2	$4K	Buy	44 +40	+1,000%	+$2.82K	﹤0.01%	6742
2018 Q1	$0	Hold	4	–	–	﹤0.01%	7210
2017 Q4	$0	Hold	4	–	–	﹤0.01%	7021
2017 Q3	$0	Hold	4	–	–	﹤0.01%	6959
2017 Q2	$0	Hold	4	–	–	﹤0.01%	6798
2017 Q1	$0	Hold	4	–	–	﹤0.01%	6880
2016 Q4	$0	Hold	4	–	–	﹤0.01%	6733
2016 Q3	$0	Hold	4	–	–	﹤0.01%	6713
2016 Q2	$0	Hold	4	–	–	﹤0.01%	6486
2016 Q1	$0	Hold	4	–	–	﹤0.01%	6306
2015 Q4	$1K	Buy	+4	New	+$734	﹤0.01%	5832
2015 Q3	–	Sell	-3	Closed	–	–	6951
2015 Q2	$0	Sell	3 -2	-40%	-$743	﹤0.01%	7120
2015 Q1	$1K	Sell	5 -4	-44%	-$2.17K	﹤0.01%	6974
2014 Q4	$4K	Buy	9 +7	+350%	+$4.76K	﹤0.01%	7017
2014 Q3	$1K	Sell	2 -110	-98%	-$96.3K	﹤0.01%	7510
2014 Q2	$101K	Buy	112 +78	+229%	+$75.8K	﹤0.01%	5405
2014 Q1	$36K	Buy	34 +33	+3,300%	+$35.8K	﹤0.01%	6251
2013 Q4	$1K	Sell	1 -72	-99%	-$71.2K	﹤0.01%	7441
2013 Q3	$88K	Buy	+73	New	+$81.1K	﹤0.01%	5709

Other funds holding LSTA

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

YCM

Yakira Capital Management Westport, Connecticut $351M AUM 21.82% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return

DAM

Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return

Rangeley Capital New Canaan, Connecticut $109M AUM 97.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

GTS Securities Miami, Florida $4.75B AUM 41.97% 1-Year Est. Return

Barclays's LSTA Position: Q2 2026 in Review

Barclays opened a new position in Lisata Therapeutics (LSTA) in Q2 2026: 70 shares worth $238. The stake represents ﹤0.01% of the portfolio and ranks #5089 among its holdings. This is a return to the name: Barclays previously reported a position in LSTA as recently as Q3 2025.

Barclays first reported a position in LSTA in Q3 2013 and has held it in 49 quarters since. The position peaked at $101K in Q2 2014. 31 funds tracked by Wall St. Rank hold LSTA as of Q2 2026.

Barclays held 70 shares of Lisata Therapeutics worth $238 as of Q2 2026.
Lisata Therapeutics was a new Barclays position in Q2 2026.
Lisata Therapeutics made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #5089 holding.
Barclays first reported a position in Lisata Therapeutics in Q3 2013 and has held it in 49 quarters since.
Barclays's Lisata Therapeutics position peaked at $101K in Q2 2014.
31 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.